- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 211/66 - Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4 having a hetero atom as the second substituent in position 4
Patent holdings for IPC class C07D 211/66
Total number of patents in this class: 67
10-year publication summary
|
4
|
4
|
7
|
4
|
4
|
3
|
6
|
7
|
3
|
0
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Mallinckrodt Inc. | 186 |
5 |
| Imago Biosciences, Inc. | 38 |
4 |
| Lhotse bio, Inc. | 11 |
4 |
| Mayo Foundation for Medical Education and Research | 3146 |
3 |
| Incyte Holdings Corporation | 652 |
3 |
| Bristol-myers Squibb Company | 4848 |
2 |
| Conopco, Inc. | 4910 |
2 |
| Glaxosmithkline Intellectual Property Development Limited | 738 |
2 |
| Johnson Matthey Public Limited Company | 1852 |
2 |
| The National Institute for Biotechnology in The Negev Ltd. | 105 |
2 |
| OPKO Health, Inc. | 51 |
2 |
| Technische Universitat Berlin | 353 |
2 |
| F. Hoffmann-La Roche AG | 7889 |
1 |
| Unilever PLC | 3256 |
1 |
| Unilever N.V. | 3157 |
1 |
| Boehringer Ingelheim International GmbH | 4732 |
1 |
| Sanofi-Aventis Deutschland GmbH | 2594 |
1 |
| Janssen Pharmaceutica N.V. | 3436 |
1 |
| Merck Patent GmbH | 5825 |
1 |
| Syngenta Participations AG | 1981 |
1 |
| Other owners | 26 |